$65m valuation loss expected at 31 December 2022

NorthWest Healthcare Management Properties Management Limited (the Manager), the manager of Vital Healthcare Property Trust (Vital) advises that it expects Vital to record a property revaluation loss of ~$65m for the six months ended 31 December 2022, with ~55% of the portfolio (by value) having been independently valued.

This preliminary draft revaluation loss represents a 1.9% decrease since 30 June 2022 (reflecting a stable Australian portfolio and a 6.5% loss for Vital's New Zealand portfolio). The loss reflects a 14 basis points softening in the weighted average cap rate for the portfolio (9 basis points softening for Australia and 26 basis points softening for New Zealand).

The indicative revaluation loss referred to above is subject to audit and will be confirmed when Vital's interim results are released (expected to occur on 23 February 2023).

•  Indicative revaluations at 31 December 2022

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

Rua Bioscience Market Update
FSF - Fonterra announces interim leadership changes
April 29th Morning Report
NZK - Blue Endeavour Pilot Farm and Wellboat Update
TRU - FY 31 March 2026 Revenue and Results Guidance Achieved
FBU - Fletcher Building sale of Fletcher Reinforcing and Wire
April 28th Morning Report
RYM - Ryman Healthcare appoints new independent director
ikeGPS 4Q FY26 and Full Year FY26 Performance Update
HGH - Heartland trading update